Abstract
BackgroundEpstein–Barr virus (EBV) is an important human pathogenic gammaherpesvirus with carcinogenic potential. The EBV transcriptome has previously been analyzed using both Illumina-based short read-sequencing and Pacific Biosciences RS II-based long-read sequencing technologies. Since the various sequencing methods have distinct strengths and limitations, the use of multiplatform approaches have proven to be valuable. The aim of this study is to provide a more complete picture on the transcriptomic architecture of EBV.MethodsIn this work, we apply the Oxford Nanopore Technologies MinION (long-read sequencing) platform for the generation of novel transcriptomic data, and integrate these with other’s data generated by another LRS approach, Pacific BioSciences RSII sequencing and Illumina CAGE-Seq and Poly(A)-Seq approaches. Both amplified and non-amplified cDNA sequencings were applied for the generation of sequencing reads, including both oligo-d(T) and random oligonucleotide-primed reverse transcription. EBV transcripts are identified and annotated using the LoRTIA software suite developed in our laboratory.ResultsThis study detected novel genes embedded into longer host genes containing 5′-truncated in-frame open reading frames, which potentially encode N-terminally truncated proteins. We also detected a number of novel non-coding RNAs and transcript length isoforms encoded by the same genes but differing in their start and/or end sites. This study also reports the discovery of novel splice isoforms, many of which may represent altered coding potential, and of novel replication-origin-associated transcripts. Additionally, novel mono- and multigenic transcripts were identified. An intricate meshwork of transcriptional overlaps was revealed.ConclusionsAn integrative approach applying multi-technique sequencing technologies is suitable for reliable identification of complex transcriptomes because each techniques has different advantages and limitations, and the they can be used for the validation of the results obtained by a particular approach.
Highlights
Epstein–Barr virus (EBV, human gammaherpesvirus 4), is a member of the Gammaherpesvirinae subfamily within the family Herpesviridae [1]
Multiplatform profiling of the EBV transcriptome In this work, we analyzed the lytic EBV transcriptome using our novel amplified and non-amplified Oxford Nanopore Technologies (ONT) sequencing dataset, as well as transcriptomic data generated by others using Pacific Biosciences (PacBio) RSII [26] and Illumina [25,26,27,28, 40, 41] platforms
PCR is used for the amplified techniques, whereas no PCR is applied for the non-amplified approaches
Summary
Epstein–Barr virus (EBV, human gammaherpesvirus 4), is a member of the Gammaherpesvirinae subfamily within the family Herpesviridae [1]. Primary EBV infection in early childhood is typically mild or symptomless. In the majority of cases, IM is a self-limiting disease, due to a vigorous T cell response directed to EBV-infected, proliferating B cells expressing viral antigens [7]. B cells are the primary targets of EBV, the virus replicates in oropharyngeal epithelial cells. Both B cells and epithelial cells are capable to produce new EBV particles that carry linear, double stranded viral genomes. Epstein–Barr virus (EBV) is an important human pathogenic gammaherpesvirus with carcinogenic potential.
Published Version (
Free)
Join us for a 30 min session where you can share your feedback and ask us any queries you have